Condition
    Moderate Evidence
    Effectiveness 3/5

    Pine Bark Extract for Varicose Veins

    Trials in venous insufficiency report reduced swelling, pain and cramping over 8-12 weeks, plausibly by reducing capillary permeability and stabilising vessel wall collagen.

    Overview

    Pine bark extract is one of the better studied supplements for venous problems. Standardised French maritime pine bark, sold as Pycnogenol, has been tested in chronic venous insufficiency, the condition that underlies most symptomatic varicose veins, and repeatedly reduced leg heaviness, swelling and cramping at 100 to 300 mg daily. The comparison trial linked to this pairing put it head to head with micronised flavonoid therapy, a prescription-grade venotonic in much of Europe, and pine bark came out ahead on both oedema and symptom scores. What it does not do is remove the varicosity: valves that have failed stay failed, and no supplement changes the mechanical problem.

    Verdict

    Likely effective

    Multiple randomised trials in chronic venous insufficiency show reduced oedema and symptom scores at 100 to 300 mg daily, including one trial outperforming a licensed flavonoid comparator. Trials are small and several share the same research group.

    Symptoms improve, veins do not disappear

    Expect less swelling, heaviness and night cramping. Structural change to a visible varicose vein requires a procedure, not a capsule.

    How It Works

    Pine bark extract is a mixture of procyanidins, catechins and phenolic acids. In venous disease its most relevant action is on the capillary wall: the procyanidins bind collagen and elastin, reduce capillary filtration and lower the leakage of fluid into tissue that produces the ankle swelling of venous insufficiency. Two further actions matter. Pine bark raises endothelial nitric oxide availability, improving microcirculatory flow in the skin overlying damaged veins, and it suppresses the low-grade inflammation driven by leucocyte trapping in congested venules, which is the process that eventually produces skin pigmentation and ulceration. These are microcirculatory effects, which is precisely why the visible macroscopic vein is unchanged.

    Pathways involved

    Reduced capillary filtration
    Collagen and elastin binding
    Endothelial nitric oxide support
    Reduced leucocyte adhesion
    Lower venular inflammation

    Dosing & Protocol

    ScenarioDoseFormTiming
    Symptom relief in venous insufficiency150 to 300 mg dailyStandardised PycnogenolDivided with meals
    Maintenance100 mg dailyStandardised PycnogenolWith breakfast
    Oedema-dominant presentation300 mg dailyStandardised PycnogenolThree divided doses
    Trial duration8 to 12 weeks--
    1. 1

      Start at 150 mg daily in divided doses· Weeks 1 to 4

      This is the most commonly used trial dose and is enough for most symptom endpoints.

    2. 2

      Raise to 300 mg if swelling dominates· Weeks 4 to 12

      Oedema endpoints responded better at the higher end of the range.

    3. 3

      Keep wearing compression· Daily

      Graduated compression stockings remain the intervention with the strongest evidence. Pine bark is an addition, not a replacement.

    4. 4

      Measure ankle circumference· Weekly

      Same ankle, same landmark, same time of evening, once a week. It is far more objective than how the leg feels.

    5. 5

      Reassess at twelve weeks· Week 12

      If circumference and heaviness have not shifted, escalate to a vascular assessment rather than a higher dose.

    Standardisation is the whole product

    Generic pine bark powder is not equivalent to extract standardised to 65 to 75 percent procyanidins. The trials used the standardised material.

    Doses cluster tightly in the literature at 100, 150 and 300 mg daily, almost always split across the day because the active procyanidins are cleared quickly. Benefits appear within four to eight weeks and fade after stopping, so this is ongoing symptom management rather than a course of treatment.

    Evidence

    The linked trial randomised 86 people with chronic venous insufficiency to pine bark extract or to a micronised purified flavonoid fraction, the standard European venotonic, and followed leg oedema and symptom scores. Pine bark produced the greater reduction in both, which is an unusually strong comparator to beat. Other randomised trials support the direction of effect for oedema, heaviness, cramping and skin microcirculation, and one reported reduced oedema during long-haul flights. The caveats are consistent across the field: sample sizes in the tens, short follow-up, and a substantial share of the work coming from research groups with a longstanding relationship to the extract manufacturer. The direction of evidence is credible; the effect size should be read conservatively.

    Studies linked to this pairing.

    Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study

    Score: 4/10
    2006
    rct
    n=86

    Cesarone MR, Belcaro G, Rohdewald P +14 more

    Pycnogenol produced greater reductions in leg edema and symptom scores than Daflon in this comparison

    View source
    Best linked evidence
    Controlled comparison trial in 86 people with chronic venous insufficiency
    Linked result
    Greater reduction in leg oedema and symptoms than the flavonoid comparator
    Studied dose
    150 to 300 mg daily for 8 to 12 weeks
    What does not change
    Vein diameter, valve competence, visible varicosity
    Certainty
    Moderate for symptoms, with sponsorship and sample size caveats

    Safety

    Pine bark extract is well tolerated. The most common complaints in trials are mild gastric discomfort, nausea and headache, usually resolved by taking it with food, and no serious adverse events have emerged across studies running up to a year. The important safety point is diagnostic rather than pharmacological. Leg swelling has causes far more serious than varicose veins, including deep vein thrombosis, heart failure and kidney disease. Sudden unilateral swelling with calf pain and warmth is a same-day medical problem, and an ulcerating or bleeding varicose vein needs vascular surgical assessment rather than a supplement.

    Sudden one-sided leg swelling is an emergency

    New unilateral swelling, calf tenderness or warmth can indicate deep vein thrombosis. Seek urgent medical care rather than starting a supplement.

    Reported effects

    Mild stomach upset
    Nausea if taken fasted
    Headache
    Dizziness at higher doses
    Avoid in pregnancy without advice

    Interactions & Conflicts

    The main interaction concern is bleeding. Pine bark procyanidins have mild antiplatelet activity, which matters for people already on anticoagulants or facing surgery, and its nitric oxide and glucose lowering effects can add to those of prescribed drugs.
    Interacts withSeverityMechanismAction
    Warfarin and direct oral anticoagulants
    moderate
    Additive antiplatelet effectUse only with clinician awareness and monitoring
    Aspirin and clopidogrel
    moderate
    Additive platelet inhibitionWatch for bruising and prolonged bleeding
    Antihypertensives
    low
    Nitric oxide mediated vasodilation may add to blood pressure loweringMonitor blood pressure in the first month
    Surgery including vein procedures
    moderate
    Bleeding riskStop at least two weeks before any planned procedure
    Immunosuppressant therapy
    low
    Pine bark has immune-modulating activityDiscuss before use

    References

    1. Cesarone MR et al. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clin Appl Thromb Hemost. 2006
    2. Gulati OP. Pycnogenol in chronic venous insufficiency and related venous disorders. Phytother Res. 2014

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.